Search research articles
Contact Us
Filters
Showing results (211-220 of 244) with videos related to
Page
of 25
Sort By:
British Journal of Cancer
|
January 25, 2023
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
Lancet (London, England)
|
September 11, 2021
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
Martin Hutchings, Rogier Mous, Michael Roost Clausen, et al.
Gerontology
|
November 30, 2022
Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study
Jonathan K L Mak, Maria Eriksdotter, Martin Annetorp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab
Luis Fayad, Fritz Offner, Mitchell R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2019
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Stephen M Ansell, Monique C Minnema, Peter Johnson, et al.
Leukemia
|
March 24, 2018
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
Shamzah Araf, Jun Wang, Koorosh Korfi, et al.
Leukemia
|
March 24, 2019
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
Shamzah Araf, Jun Wang, Koorosh Korfi, et al.
The EMBO Journal
|
June 23, 2014
Molecular mechanism of ligand recognition by membrane transport protein, Mhp1
Katie J Simmons, Scott M Jackson, Florian Brueckner, et al.
Eclinicalmedicine
|
January 9, 2023
The iR<sup>2</sup> regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: A multicentre, non-randomised, open-label phase 2 study
Radhakrishnan Ramchandren, Peter Johnson, Nilanjan Ghosh, et al.
Haematologica
|
July 7, 2018
Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant
Shamzah Araf, Jun Wang, Margaret Ashton-Key, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 244) with videos related to
Sort By:
Page
of 25
British Journal of Cancer
|
January 25, 2023
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care
Maria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
Lancet (London, England)
|
September 11, 2021
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
Martin Hutchings, Rogier Mous, Michael Roost Clausen, et al.
Gerontology
|
November 30, 2022
Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study
Jonathan K L Mak, Maria Eriksdotter, Martin Annetorp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab
Luis Fayad, Fritz Offner, Mitchell R Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2019
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Stephen M Ansell, Monique C Minnema, Peter Johnson, et al.
Leukemia
|
March 24, 2018
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
Shamzah Araf, Jun Wang, Koorosh Korfi, et al.
Leukemia
|
March 24, 2019
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
Shamzah Araf, Jun Wang, Koorosh Korfi, et al.
The EMBO Journal
|
June 23, 2014
Molecular mechanism of ligand recognition by membrane transport protein, Mhp1
Katie J Simmons, Scott M Jackson, Florian Brueckner, et al.
Eclinicalmedicine
|
January 9, 2023
The iR<sup>2</sup> regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: A multicentre, non-randomised, open-label phase 2 study
Radhakrishnan Ramchandren, Peter Johnson, Nilanjan Ghosh, et al.
Haematologica
|
July 7, 2018
Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant
Shamzah Araf, Jun Wang, Margaret Ashton-Key, et al.
Page
of 25